Recently, there’s been a surge of interest in the potential of magic mushrooms to help manage a range of mental health disorders, particularly depression. There’s a growing trend of ingesting a standard dose of around 25 mg of the active compound, available at a mushroom dispensary. This dosage has demonstrated promise in providing relief and could supplement conventional depression treatments.
Academic research suggests that psilocybin, the active ingredient in magic mushrooms, has resulted in promising findings in the treatment of depression.
Key Points:
- Psilocybin may improve depression symptoms in as short as eight days.
- The side effects of psilocybin are usually tolerable, varying from mild to moderate.
- A 25mg dose of psilocybin can lead to perception changes, mood shifts, increased creativity, and a feeling of unity.

One Dose Could Be Enough
A recent study employed a rigorous method, using a randomized, multi-blinded design to compare a single dose of psilocybin to an active placebo (niacin). The research evaluated the onset, benefits duration, and safety of psilocybin over six weeks.
The Study Participants
The study involved individuals aged 21 to 65 who met the criteria for Major Depressive Disorder (MDD) according to the DSM-5 (Diagnostic and Statistical Manual of Mental Disorders), and were undergoing a depressive episode of at least 60 days at the time.
The Procedure
Participants received either a single 25-mg oral dose of psilocybin or a 100-mg dose of niacin. Niacin served as an active placebo, causing an immediate physiological response (flushing) to maintain the blinding integrity.
The psilocybin and niacin placebo were given following a standard “set and setting” protocol. The preparatory sessions, led by two facilitators, lasted between 6 and
A session of dosage typically lasted for 7 to 10 hours, conducted in a relaxed environment. Participants were prompted to contemplate their experiences four hours after receiving the dose.
Insights Gained from the Study
Depression symptoms appeared to decrease merely eight days after the psilocybin administration. This positive effect remained consistent during the six-week follow-up. According to the Montgomery-Asberg Depression Rating Scale (MADRS), it showed higher response and remission rates compared to other psilocybin studies and Treatment-Resistant Depression.
When compared to niacin, psilocybin exhibited better psychosocial functioning. The psilocybin usage displayed potential in numerous aspects like reducing the overall severity of the disease, alleviating anxiety and self-reported depressive symptoms, and improving the quality of life.
The majority of participants tolerated the compound well, with only minor or moderate side effects primarily after the first dose. However, compared to niacin, psilocybin treatment had more frequent and intense side effects, which is consistent with our current understanding of its impacts.
The researchers highlighted that psychedelics such as psilocybin could produce side effects that standard rating scales might not always capture or might reveal previously undetected psychiatric disorders, even while effectively treating specific conditions.
What Does a 25-mg Dose Mean?
Generally, a psychedelic dose varies between 15 to 25 milligrams of psilocybin (1.5 to 2.5 grams of dried mushrooms). This is the standard dosage for individuals aiming for the full psychedelic effects of magic mushrooms.
This dosage can result in altered perception, mood shifts, enhanced creativity, and a feeling of unity with the environment. While minor visual effects might occur, intense hallucinations are rare. It feels like entering a vivid dream-like world where reality blends effortlessly with a fascinating mix of visual and auditory sensations.
These euphoric feelings often express in the form of dance, gentle movements, or just surrendering to the psychedelic rhythm. The experience typically lasts between 4 to 8 hours. At this level, visual distortions may become more distinct. Patterns seem to come alive and change, and your surroundings seem to pulsate with energy.
This dosage can be controlled, but it demands a well-managed setting and a positive mindset. It offers a journey filled with awe and curiosity, urging you to delve into the realm of consciousness. with anticipatory excitement.
- An intensified enhancement in color perception.
- Vision alterations, such as the perception of objects shifting or “breathing”.
- The occurrence of synesthesia, such as “seeing sounds” or “hearing colors”.
- A deepened understanding and appreciation of music.
- Frequent episodes of laughter.
- Alterations in touch sensations.
- Engagement in introspection.
- Feelings of extreme joy or euphoria.
- Distortions in the perception of time.
- Increases in heart rate and blood pressure.
Variety of Products at Magic Mushroom Retailers
Magic mushroom stores offer a wide range of products infused with psilocybin. These stores stock various options including dried mushrooms, edibles, capsules, and beverages, among others. Dried mushrooms are particularly popular.
Health Canada recognizes over 200 species of magic mushrooms, with Psilocybe cubensis being a common variant sold. This strain comes in several types, providing an extensive selection for customers, similar to the choices available at cannabis dispensaries.
Other Shroom Products:
Edibles | Food products such as gummies and chocolates infused with psilocybin. The dosage is made convenient as the manufacturers indicate the amount per serving. |
Capsules | These are tasteless and can be easily integrated into your wellness routine. They contain only small quantities to provide a subtle enhancement to your day-to-day activities. |
Beverages | Similar to edibles, but in drinkable form. They come in a variety of forms such as chocolate, coffee, or tea. |
How to Determine Your Dosage at Magic Mushroom Dispensaries
While magic mushrooms are not a typical treatment for depression, Canada has taken a progressive step. They have permitted the testing and medical use of psilocybin, a Schedule I substance under the Controlled Drugs and Substances Act, for certain patients dealing with severe major depressive disorder. This move could potentially benefit tens of thousands
Individuals grappling with anxiety and depression often seek alternative treatments through clinical trials.
Common Queries
Can you buy psilocybin at a medicinal mushroom dispensary?
A medicinal mushroom dispensary generally carries products like Reishi, Turkey Tail, and Lion’s Mane. If you’re curious about the world of mushrooms, an online magic mushroom dispensary could be your ideal destination. These dispensaries offer a range of mushroom products, including dried mushrooms and other psychedelic substances.
Is a 25 mg dosage effective for depression treatment?
Studies are still being conducted on the appropriate psilocybin dosages for depression treatment. Some research is centered on lower dosages, while others examine higher amounts of psilocybin. One potential approach is to begin with a microdose and gradually increase the dosage.
Can you buy shrooms in Toronto?
Online mushroom retailers make shopping possible from anywhere in Canada. Regardless of your province or city, these online services assure delivery to your home.
What is the least expensive product at an online mushroom store?
Dried mushrooms are often the first choice for customers due to the various quantities available. The price may differ based on whether you require a small amount like 1 gram or intend to purchase in bulk. While edibles and other products are priced reasonably, they may not be as economical as dried mushrooms.
Could a single shroom dose help alleviate depression?
Some studies indicate that a one-time use might be enough to lessen depression symptoms. However, it’s important to remember that study participants also underwent talk therapy alongside the treatment. The combination of psychedelic therapy and therapeutic sessions appears to yield the best results.
About the Author
This article was penned by Charles L. Raison et al.; Jeremy D. Coplan, MD and Dorothy P. Reddy, MD; Albert Garcia-Romeu, Frederick S Barrett, Theresa M Carbonaro, Matthew W Johnson, and Roland R Griffiths; Vince Polito. and Richard J. Stevenson; Rebecca Smausz, Joanna Neill, and John Gigg.
Affiliated Entities:
- Usona Institute, situated in Fitchburg, Wisconsin
- SUNY Downstate Medical Center, located in Brooklyn, New York
- Neurogenesis Clinics, based in Brooklyn, New York
- The Department of Psychiatry and Behavioral Sciences at Johns Hopkins University School of Medicine, Baltimore, MD, USA
- Center for Psychedelic and Consciousness Research at Johns Hopkins University School of Medicine, Baltimore, MD, USA
- Department of Neuroscience at Johns Hopkins University School of Medicine, Baltimore, MD, USA
- Department of Psychiatry and Behavioral Sciences at Johns Hopkins University School of Medicine, Baltimore, MD, USA
- Department of Cognitive Science at Macquarie University, Sydney, Australia
- Department of Psychology at Macquarie University, Sydney, Australia
- The Division of Neuroscience and Experimental Psychology, Faculty of Biology, Medicine and Health at The University of Manchester, UK
- Division of Pharmacy and Optometry, Faculty of Biology, Medicine and Health at The University of Manchester, UK
- Medical Psychedelics Working Group, associated with Drug Science, UK